The Nova Scotia Health Authority will organize five startup pitch competitions this year, aimed at identifying new technologies to help address growing problems faced by the provincial medical system.

Announced Friday during an event at the Volta

Halifax-area marketing agency Revolve has bought the book of business of web development company Code + Mortar, formerly called Norex, for an undisclosed price.

The two parties announced the acquisition on Friday, as Revolve also unveiled the

Our Jobs of the Week column today features openings for a pair of positions in the marketing sphere -- Director of Marketing at Moncton-based SnapAp, and Performance Marketing Manager at Dash Hudson of Halifax.

Dash Hudson is a visual marketing

Not only has Potential Motors pivoted to become a software company, but the Fredericton startup has brought two of New Brunswick’s most successful tech entrepreneurs on to its team.

Chris Newton and Marcel LeBrun have joined Potential Motors as

A new alliance of representatives for clean energy development was announced on Monday.

The Atlantic Clean Energy Alliance will work to foster energy innovation in the New Brunswick economy.

Representatives include the University of New

Having worked for decades in the technology industry in Israel, Alicia Ismach sees huge opportunities for Atlantic Canada’s tech sector in general and financial technology, or fintech, in particular.

The native of Argentina was hired as

Woodstock, NB-based Xplornet Communications Inc., which owns a hiybrid fiber wireless and satellite network, has reportedly agreed to be bought by a private equity investor for about US$2 billion (C$2.7 billion).

Citing people familiar with the

The AquaHacking Challenge, a national competition that encourages post-secondary students to find solutions to problems plaguing freshwater supplies, has launched in Atlantic Canada.

The East Coast program was launched Wednesday at an event at

St. John’s-based PolyUnity has joined Eastern Health Authority’s Living Labs initiative, which will support the young company in its mission to help train doctors around the world with the aid of 3D printing.  

Founded by three med students at

Dartmouth biotech company IMV on Tuesday revealed “breakthrough” results in the Phase 2 clinical trials of its flagship drug DPX-Survivac, which sparked a sell-off of its shares that was as puzzling as it was dramatic.

IMV, which specializes in

Appili Therapeutics Inc., the Halifax company dedicated to fighting infectious diseases, has raised $10.25 million by selling shares and warrants to mainly institutional investors.

The fundraising round – the company’s first since it listed on the

Milk Moovement of St. John’s has been accepted into the Thrive accelerator in Silicon Valley, and will receive a US$100,000 (C$133,000) investment on joining the program.

SVG Ventures-Thrive, the California group that says it operates the